[Hytrin[R]], Tamsulosin [Flomax[R]]); 5 alpha-reductase inhibitors (dutasteride [Avodart[R]], finasteride [Proscar[R]]), which inhibit prostate growth through impeding dihydro-testosterone production; a combination of doxa zosin (Cardura[R]) and finasteride also may be used (Collins, 2016; Lynn, 2017; Smart, 2016).
also has a longer half-life (12 hours) and reaches peak plasma concentration in 1 hour.
Objectives: To evaluate and compare anterior segment changes in patients taking alpha-1 ([alpha]1) blockers (tamsulosin, terazosin
, doxazosin, alfuzosin) for benign prostatic hypertrophy, during drug intake and drug-free period, using ultrasound biomicroscopy (UBM).
Also, because the drugs can reduce blood pressure, they should not be used with nitrates (nitroglycerin), and should be used with caution in men taking alpha-blocker drugs, like tamsulosin (Flomax[R]), doxazosin (Cardura[R]), and terazosin
1%, Torsemide Injection 10 mg/ml, Terazosin
Tablets USP 2 mg
Efficacy and safety of combined therapy with terazosin
and tolterodine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A prospective study.
The efficacy of terazosin
, finasteride, or both in benign prostatic hyperplasia.
2013) (discussing antitrust class action suit where manufacturer illegally delayed entry of generic into market); In re Terazosin
Hydrochloride Antitrust Litig.
, doxazosin, prazosin, atenolol, furosemide, nifedipine, verapamil, diltiazem, isosorbide dinitrate, lisinopril, amitriptyline, chlorpromazine, or prochlorperazine), psychotropic agents (i.
Less frequent but persistent AD was medically managed with oral labetalol and terazosin
, as well as nifedipine and Nitro-Bid cream as needed.
A randomized, placebo-controlled multicentre study of the efficacy and safety of terazosin
in the treatment of benign prostatic hypeiplasia.
Doxazosin, prazosin, and terazosin
are examples of alpha-adrenergic blocking agents and are frequently reserved for those patients on HD with resistant hypertension (Ram & Fenves, 2009).